ロード中...
Adenosine hypothesis of schizophrenia –opportunities for pharmacotherapy
Pharmacotherapy of schizophrenia based on the dopamine hypothesis remains unsatisfactory for the negative and cognitive symptoms of the disease. Enhancing N-methyl-d-aspartate receptors (NMDAR) function is expected to alleviate such persistent symptoms, but successful development of novel clinically...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3119785/ https://ncbi.nlm.nih.gov/pubmed/21315743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2011.01.048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|